Ziwei Wang

2.1k total citations
84 papers, 1.5k citations indexed

About

Ziwei Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ziwei Wang has authored 84 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 33 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Ziwei Wang's work include Cancer-related molecular mechanisms research (20 papers), MicroRNA in disease regulation (15 papers) and Circular RNAs in diseases (13 papers). Ziwei Wang is often cited by papers focused on Cancer-related molecular mechanisms research (20 papers), MicroRNA in disease regulation (15 papers) and Circular RNAs in diseases (13 papers). Ziwei Wang collaborates with scholars based in China, United States and Ukraine. Ziwei Wang's co-authors include Anqi Cheng, Lang Zha, Xiong Guo, Hui Li, Xudong Peng, Jianjun Liu, Lei Chen, Junqing Zhang, Xiaohui Guo and Jingjing Li and has published in prestigious journals such as Journal of Applied Physics, Journal of Hazardous Materials and Brain Research.

In The Last Decade

Ziwei Wang

76 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziwei Wang China 24 1.0k 572 203 140 111 84 1.5k
Yi Jin China 22 1.0k 1.0× 758 1.3× 220 1.1× 159 1.1× 164 1.5× 66 1.6k
Guiying Wang China 22 1.2k 1.2× 512 0.9× 330 1.6× 143 1.0× 190 1.7× 100 1.7k
Matthew N. McCall United States 21 1.1k 1.1× 644 1.1× 104 0.5× 101 0.7× 128 1.2× 61 1.7k
Francesca Pagano Italy 20 1.2k 1.2× 464 0.8× 151 0.7× 122 0.9× 213 1.9× 63 1.9k
Wenqiang Yu China 19 1.1k 1.1× 630 1.1× 95 0.5× 135 1.0× 119 1.1× 55 1.8k
Na Che China 22 952 0.9× 536 0.9× 430 2.1× 169 1.2× 106 1.0× 59 1.5k
Yong Han China 22 850 0.8× 403 0.7× 330 1.6× 225 1.6× 139 1.3× 82 1.5k
Byunghee Kang South Korea 9 964 0.9× 310 0.5× 237 1.2× 184 1.3× 117 1.1× 19 1.6k
Shu‐Juan Xie China 16 836 0.8× 516 0.9× 118 0.6× 96 0.7× 59 0.5× 44 1.2k
Yufeng Yao China 24 798 0.8× 378 0.7× 132 0.7× 142 1.0× 148 1.3× 52 1.5k

Countries citing papers authored by Ziwei Wang

Since Specialization
Citations

This map shows the geographic impact of Ziwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziwei Wang more than expected).

Fields of papers citing papers by Ziwei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziwei Wang. The network helps show where Ziwei Wang may publish in the future.

Co-authorship network of co-authors of Ziwei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ziwei Wang. A scholar is included among the top collaborators of Ziwei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziwei Wang. Ziwei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ziwei, et al.. (2025). 6PPD induces apoptosis and autophagy in SH-SY5Y cells via ROS-mediated PI3K/AKT/mTOR pathway: In vitro and in silico approaches. Toxicology. 513. 154091–154091. 2 indexed citations
2.
Zhang, Zhifeng, Siyu Zhu, Ziwei Wang, et al.. (2025). USP41 regulates glioma malignancy through Notch1 activation: Insights from in vitro and in vivo studies. Pathology - Research and Practice. 275. 156217–156217.
3.
Wadgaonkar, Priya, Ziwei Wang, & Fei Chen. (2024). Endoplasmic reticulum stress responses and epigenetic alterations in arsenic carcinogenesis. Environmental Pollution. 347. 123565–123565. 7 indexed citations
5.
Chen, Zhenzhou, et al.. (2024). The METTL3/TRAP1 axis as a key regulator of 5-fluorouracil chemosensitivity in colorectal cancer. Molecular and Cellular Biochemistry. 480(3). 1865–1889. 2 indexed citations
6.
Wang, Ting, Ziwei Wang, Xingcai Zhang, et al.. (2023). Next-generation CRISPR-based diagnostic tools for human diseases. TrAC Trends in Analytical Chemistry. 168. 117328–117328. 23 indexed citations
7.
Wang, Jinghua, Yanjiao Wang, Ziwei Wang, et al.. (2023). Ten-Day Vonoprazan-Amoxicillin Dual Therapy vs Standard 14-Day Bismuth-Based Quadruple Therapy for First-Line Helicobacter pylori Eradication: A Multicenter Randomized Clinical Trial. The American Journal of Gastroenterology. 119(4). 655–661. 22 indexed citations
8.
Ma, Caixia, Tong Sun, Minghui Yang, et al.. (2023). Circ-sh3rf3/GATA-4/miR-29a regulatory axis in fibroblast–myofibroblast differentiation and myocardial fibrosis. Cellular and Molecular Life Sciences. 80(2). 50–50. 17 indexed citations
9.
Hu, Zhiyong, et al.. (2022). A deep feature extraction approach for bearing fault diagnosis based on multi-scale convolutional autoencoder and generative adversarial networks. Measurement Science and Technology. 33(6). 65013–65013. 17 indexed citations
10.
Guo, Xiong, et al.. (2022). Identification and Characterization of the Roles of circCASP9 in Gastric Cancer Based on a circRNA‐miRNA‐mRNA Regulatory Network. Oxidative Medicine and Cellular Longevity. 2022(1). 9416825–9416825. 9 indexed citations
11.
Feng, Qingqing, Hongli Zhang, Ziwei Wang, et al.. (2022). Deficiency of miRNA-149-3p shaped gut microbiota and enhanced dextran sulfate sodium-induced colitis. Molecular Therapy — Nucleic Acids. 30. 208–225. 12 indexed citations
13.
Guo, Xiong, et al.. (2020). Circular RNA circREPS2 Acts as a Sponge of miR-558 to Suppress Gastric Cancer Progression by Regulating RUNX3/β-catenin Signaling. Molecular Therapy — Nucleic Acids. 21. 577–591. 38 indexed citations
14.
Guo, Xiong, et al.. (2020). <p>Circ-OXCT1 Suppresses Gastric Cancer EMT and Metastasis by Attenuating TGF-β Pathway Through the Circ-OXCT1/miR-136/SMAD4 Axis</p>. OncoTargets and Therapy. Volume 13. 3987–3998. 34 indexed citations
15.
Gong, Lei, Mingyang Ren, Zhenbing Lv, Yuling Yang, & Ziwei Wang. (2018). miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo. DNA and Cell Biology. 37(5). 501–511. 42 indexed citations
17.
Wang, Ziwei, et al.. (2016). HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer. Oncology Reports. 37(1). 185–192. 33 indexed citations
18.
Zha, Lang, et al.. (2014). Aberrant Expression of the Autocrine Motility Factor Receptor Correlates with Poor Prognosis and Promotes Metastasis in Gastric Carcinoma. Asian Pacific Journal of Cancer Prevention. 15(2). 989–997. 14 indexed citations
19.
Wang, Ruijue, Yang Bai, Jianbo Huang, et al.. (2013). Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment. Medical Oncology. 30(3). 687–687. 15 indexed citations
20.
Zha, Lang, et al.. (2012). Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells. Molecular and Cellular Biochemistry. 364(1-2). 243–251. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026